Merck KGaA (OTCMKTS:MKGAF) Trading Down 4.8% – What’s Next?

Shares of Merck KGaA (OTCMKTS:MKGAF) were down 4.8% during mid-day trading on Monday . The stock traded as low as $122.3570 and last traded at $122.3930. Approximately 901 shares were traded during mid-day trading, an increase of 61% from the average daily volume of 558 shares. The stock had previously closed at $128.5830.

Merck KGaA Stock Performance

The firm has a market cap of $16.25 billion, a P/E ratio of 19.19 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock’s 50-day moving average is $147.34 and its 200 day moving average is $139.78.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.